# Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)

> **NCT02952599** · — · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 352 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Edoxaban

## Key facts

- **NCT ID:** NCT02952599
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-10-29
- **Final completion:** 2019-10-29
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2019-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952599, "Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02952599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*